CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Operating Activities
Net income	$ 147.0	$ 53.0
Adjustments to reconcile net income to net cash flows provided by (used in) operating activities:
Depreciation, amortization and accretion	21.0	15.0
Provision for credit losses	14.1	18.0
Deferred tax expense (benefit)	2.0	5.0
Loans originated for sale	(215.0)	(354.0)
Loans sold	221.0	410.0
Net gain on sale of loans	3.0	(15.0)
Net change in:
Interest receivable	(4.0)	2.0
Interest payable	5.0	(2.0)
Bank owned life insurance, excluding purchases	(2.0)	(1.0)
Other, net	(173.0)	227.0
Net cash flows provided by operating activities	19.0	358.0
Investing Activities
Net change in loans and leases, excluding sales and transfers	(415.0)	(74.0)
Debt securities available for sale:
Purchases	0.0	(398.0)
Sales	0.0	287.0
Maturities/payments	116.0	244.0
Debt securities held to maturity:
Purchases	(75.0)	(243.0)
Maturities/payments	90.0	190.0
Increase in premises and equipment	(33.0)	(27.0)
Net cash received in business acquisition	0.0	75.0
Net cash flows (used in) provided by investing activities	(317.0)	54.0
Financing Activities
Demand (non-interest bearing and interest bearing) and savings accounts	(1,717.0)	478.0
Time deposits	1,136.0	(131.0)
Short-term borrowings	776.0	(125.0)
Proceeds from issuance of long-term borrowings	512.0	3.0
Repayment of long-term borrowings	(306.0)	(206.0)
Repurchases of common stock	(12.0)	(30.0)
Cash dividends paid:
Preferred stock	(2.0)	(2.0)
Common stock	(44.0)	(43.0)
Other, net	4.0	8.0
Net cash flows provided by (used in) financing activities	347.0	(48.0)
Net Increase in Cash and Cash Equivalents	49.0	364.0
Cash and cash equivalents at beginning of period	1,674.0	3,493.0
Cash and Cash Equivalents at End of Period	$ 1,723.0	$ 3,857.0